Related Experiment Videos
Delivery strategies for antiparasitics
Oliver Kayser1, Albrecht F Kiderlen
1Freie Universität Berlin, Institute of Pharmacy, Pharmaceutical Technology, Biopharmacy and Biotechnology, Kelchstrasse 31, 12169 Berlin, Germany. kayser@zedat.fu-berlin.de
Expert Opinion on Investigational Drugs
|January 31, 2003
Summary
Rational drug design for antiparasitic therapies involves optimizing drug carriers and delivery strategies. This review covers nano- and microparticles, liposomes, and other systems for treating parasitic diseases like malaria and leishmaniasis.
Area of Science:
- Drug development and formulation science
- Parasitology and infectious diseases
- Biotechnology and nanomedicine
Background:
- Modern drug development requires tailored strategies for infectious agents and diseases.
- Antiparasitic drug formulation presents unique challenges due to pathogen peculiarities.
- Optimizing drug delivery is crucial for enhancing therapeutic efficacy.
Purpose of the Study:
- To review rational design principles for antiparasitic drug formulations.
- To discuss various drug carrier systems and their functional properties.
- To evaluate the therapeutic efficacy of these systems against specific parasitic diseases.
Main Methods:
- Review of existing literature on drug carrier systems for antiparasitic drugs.
- Analysis of delivery systems including nano- and microparticles, liposomes, emulsions, cochleates, and bioadhesive macromolecules.
- Discussion of biopharmaceutical and pathophysiological parameters influencing drug delivery.
Main Results:
- Various carrier systems show promise for antiparasitic drug delivery.
- Efficacy demonstrated for leishmaniasis, human African trypanosomiasis, cryptosporidiosis, malaria, and schistosomiasis.
- Key parameters for successful application include route of administration and targeting intracellular pathogens.
Conclusions:
- Optimized drug carrier systems are essential for effective antiparasitic therapies.
- Rational design must consider disease-specific and pathogen-specific factors.
- Future research should focus on improving body distribution and intracellular targeting.